Correlation Between Taigen Biopharmaceutica and Liton Technology

Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and Liton Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and Liton Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and Liton Technology, you can compare the effects of market volatilities on Taigen Biopharmaceutica and Liton Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of Liton Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and Liton Technology.

Diversification Opportunities for Taigen Biopharmaceutica and Liton Technology

-0.64

Correlation Coefficient

Taigen Biopharmaceutica  Liton Technology

Excellent diversification

The 3 months correlation between Taigen and Liton is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and Liton Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Liton Technology and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with Liton Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Liton Technology has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and Liton Technology go up and down completely randomly.

Pair Corralation between Taigen Biopharmaceutica and Liton Technology

Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the Liton Technology. But the stock apears to be less risky and, when comparing its historical volatility, Taigen Biopharmaceuticals Holdings is 1.19 times less risky than Liton Technology. The stock trades about -0.19 of its potential returns per unit of risk. The Liton Technology is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  3,425  in Liton Technology on October 7, 2024 and sell it today you would earn a total of  440.00  from holding Liton Technology or generate 12.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Taigen Biopharmaceuticals Hold  vs.  Liton Technology

Taigen Biopharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Liton Technology

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Liton Technology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Liton Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Taigen Biopharmaceutica and Liton Technology

The main advantage of trading using opposite Taigen Biopharmaceutica and Liton Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, Liton Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Liton Technology will offset losses from the drop in Liton Technology's long position.

The idea behind Taigen Biopharmaceuticals Holdings and Liton Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..